vision changes on tirzepatide Comparative ocular outcomes of versus other anti-obesity medications in people with obesity Semaglutide, Tirzepatide Linked to Small
Description
Two patients with cardiovascular deaths had no prior cardiovascular risk factors other than T2DM
personal factors matter more than the small difference in average outcomes Switching Between Medications Many patients start with one medication and switch to the other
Cell Endocrinol
Strengths The most powerful GLP-1 medication studied to date
Earlier phase 2 trials tested different timing protocols, including 2 week escalations and faster progressions to higher doses
And the result is worse sulfur burps than either factor would produce independently
